Cargando…
A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1
Synaptic transmission and long-term potentiation (LTP) in the CA1 region of hippocampal slices have been studied during ageing of a double transgenic mouse strain relevant to early-onset familial Alzheimer's disease (AD). This strain, which over-expresses both the 695 amino acid isoform of huma...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912307/ https://www.ncbi.nlm.nih.gov/pubmed/20630068 http://dx.doi.org/10.1186/1756-6606-3-21 |
_version_ | 1782184577444347904 |
---|---|
author | Fitzjohn, Stephen M Kuenzi, Frederick Morton, Robin A Rosahl, Thomas W Lewis, Huw Smith, David Seabrook, Guy R Collingridge, Graham L |
author_facet | Fitzjohn, Stephen M Kuenzi, Frederick Morton, Robin A Rosahl, Thomas W Lewis, Huw Smith, David Seabrook, Guy R Collingridge, Graham L |
author_sort | Fitzjohn, Stephen M |
collection | PubMed |
description | Synaptic transmission and long-term potentiation (LTP) in the CA1 region of hippocampal slices have been studied during ageing of a double transgenic mouse strain relevant to early-onset familial Alzheimer's disease (AD). This strain, which over-expresses both the 695 amino acid isoform of human amyloid precursor protein (APP) with K670N and M671L mutations and presenilin 1 with the A246E mutation, has accelerated amyloidosis and plaque formation. There was a decrease in synaptic transmission in both wildtype and transgenic mice between 2 and 9 months of age. However, preparing slices from 14 month old animals in kynurenic acid (1 mM) counteracted this age-related deficit. Basal transmission and paired-pulse facilitation was similar between the two groups at all ages (2, 6, 9 and 14 months) tested. Similarly, at all ages LTP, induced either by theta burst stimulation or by multiple tetani, was normal. These data show that a prolonged, substantially elevated level of Aβ are not sufficient to cause deficits in the induction or expression of LTP in the CA1 hippocampal region. |
format | Text |
id | pubmed-2912307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29123072010-07-30 A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1 Fitzjohn, Stephen M Kuenzi, Frederick Morton, Robin A Rosahl, Thomas W Lewis, Huw Smith, David Seabrook, Guy R Collingridge, Graham L Mol Brain Research Synaptic transmission and long-term potentiation (LTP) in the CA1 region of hippocampal slices have been studied during ageing of a double transgenic mouse strain relevant to early-onset familial Alzheimer's disease (AD). This strain, which over-expresses both the 695 amino acid isoform of human amyloid precursor protein (APP) with K670N and M671L mutations and presenilin 1 with the A246E mutation, has accelerated amyloidosis and plaque formation. There was a decrease in synaptic transmission in both wildtype and transgenic mice between 2 and 9 months of age. However, preparing slices from 14 month old animals in kynurenic acid (1 mM) counteracted this age-related deficit. Basal transmission and paired-pulse facilitation was similar between the two groups at all ages (2, 6, 9 and 14 months) tested. Similarly, at all ages LTP, induced either by theta burst stimulation or by multiple tetani, was normal. These data show that a prolonged, substantially elevated level of Aβ are not sufficient to cause deficits in the induction or expression of LTP in the CA1 hippocampal region. BioMed Central 2010-07-14 /pmc/articles/PMC2912307/ /pubmed/20630068 http://dx.doi.org/10.1186/1756-6606-3-21 Text en Copyright ©2010 Fitzjohn et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Fitzjohn, Stephen M Kuenzi, Frederick Morton, Robin A Rosahl, Thomas W Lewis, Huw Smith, David Seabrook, Guy R Collingridge, Graham L A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1 |
title | A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1 |
title_full | A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1 |
title_fullStr | A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1 |
title_full_unstemmed | A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1 |
title_short | A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1 |
title_sort | study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912307/ https://www.ncbi.nlm.nih.gov/pubmed/20630068 http://dx.doi.org/10.1186/1756-6606-3-21 |
work_keys_str_mv | AT fitzjohnstephenm astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT kuenzifrederick astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT mortonrobina astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT rosahlthomasw astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT lewishuw astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT smithdavid astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT seabrookguyr astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT collingridgegrahaml astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT fitzjohnstephenm studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT kuenzifrederick studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT mortonrobina studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT rosahlthomasw studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT lewishuw studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT smithdavid studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT seabrookguyr studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 AT collingridgegrahaml studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1 |